Roy Lester Freeman's Net Worth
$0
Who is Roy Lester Freeman?
Roy Lester Freeman does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Inhibikase Therapeutics, Inc..
SEC CIK
Roy Lester Freeman's CIK is 0001799732
Past Insider Trading and Trends
2020 was Roy Lester Freeman's most active year for acquiring shares with 1 total transactions. Roy Lester Freeman's most active month to acquire stocks was the month of May. 2022 saw Roy Lester Freeman paying a total of $0.00 for 40,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Inhibikase Therapeutics, Inc. (IKT) Snapshot price: $1.35
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||